AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (April 15, 2004). doi:10.1152/ajpgi.00514.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/G518    most recent
00514.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiemer, A. K.
Right arrow Articles by Vollmar, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiemer, A. K.
Right arrow Articles by Vollmar, A. M.
Submitted on December 10, 2003
Accepted on April 9, 2004

ANP-INDUCED DECREASE OF IRON REGULATORY PROTEIN ACTIVITY IS INDEPENDENT OF HO-1 INDUCTION

Alexandra K. Kiemer1*, Anke C. Fornges1, Kostas Pantopoulos2, Manfred Bilzer3, Bill Andriopoulos2, Tobias Gerwig1, Silke Kenngott3, Alexander L. Gerbes3, and Angelika M. Vollmar4

1 Department of Pharmacy, University of Munich, Munich, Germany; Department of Medicine II, University of Munich, Munich, Germany
2 Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada
3 Department of Medicine II, University of Munich, Munich, Germany
4 Department of Pharmacy, University of Munich, Munich, Germany

* To whom correspondence should be addressed. E-mail: kiemer{at}scripps.edu.

ANP-preconditioned livers are protected from ischemia/reperfusion injury. ANP-treated organs show increased expression of HO-1. Since HO-1 liberates bound iron, aim of our study was to determine whether ANP affects iron regulatory protein (IRP) activity and thus the levels of ferritin. Methods: Rat livers were perfused with KH-buffer (± ANP, 8-Br-cGMP, SnPP, 20 min), stored in UW-solution (4°C, 24 h), and reperfused (120 min). IRP activity was assessed by gelshift assays; ferritin, IRP phosphorylation, and PKC localization by Western blot. Results: Control livers displayed decreased IRP activity at the end of ischemia but no change in ferritin content during ischemia and reperfusion. ANP-pretreated livers showed reduced IRP activity, an effect mimicked by 8-Br-cGMP. Ferritin levels were increased in ANP-pretreated organs. Simultaneous perfusion of livers with ANP and SnPP did not reduce ANP-induced action arguing against a role of HO-1 for the changes in IRP activity. ANP and 8-Br-cGMP decreased membrane localization of PKC{alpha} and {epsilon}, but this modulation of PKC seems not related to inhibition of IRP binding. Conclusion: This work shows the cGMP-mediated attenuation of IRP binding activity by ANP which results in increased hepatic ferritin levels. This change in IRPs is independent of ANP-induced HO-1 and reduced PKC activation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.